三生国健药业(上海)股份有限公司

曲目:三生国健药业(上海)股份有限公司
NJ:
时间:2019/05/22
发行:



        

        

        
        

        三生国健医药品(上海)股份股份有限公司(省略“三生国健”):

        2002年,奇纳中信广场结派与兰生国健医药品接纳新成员投资额发觉生物医药高新技术聚会——上海中信广场国健医药品股份股份有限公司;2015年,三生制药业股份股份有限公司是香港股票上市的公司。,并更名为三圣国健医药品(上海)股份有限公司。。十几年来,三生国健前后专注于反据的详述与开展、中试与勤劳化,一个人孤独对称体药物研究与切开平台,精通的研究与切开和勤劳化的核心技术,参加技术革新。。公司有钱人经过陈述食药监总局(CFDA)GMP验明的3条750升、两条3000升对称体药物流水线;契合欧盟基准的6条5000升对称体药物流水线于2015年使臻于完善建造并成试工厂,工厂一定尺寸的和大规模的把持程度在DO中带头。三圣国民的安康供应自身免疫作用的草木、果心、抗器官移植反对票反射等重大疾病球的靶子药物,不竭切开新药的生产能力,现已开展适合对称体药学球的龙头聚会。。

        简介(英文):
Sunshine Guojian Pharmaceutical (上海) Co., Ltd. (日光 Guojian),whose predecessor is Shanghai CP Guojian Pharmaceutical Co., Ltd. jointly invested in 2002 as a biomedical high-tech enterprise by China CITIC Group and the Lansheng Guojian Pharmaceutical Co., Ltd., is established in 2015 and integrated into the Sunshine Pharmaceutical Group, a Hong Kong listed company, upon equity 投资额。 Over the past decade, Sunshine Guojian has committed to the R&D, pilot scale development and industrialization of antibody 药物。 The company has built up a 自营的 antibody drug discovery platform with core technologies and know-hows, as well as led or participated in drafting of national standards in antibody drug quality 把持。 Sunshine Guojian’s antibody drug production lines (3*750L and 2*3000L) has been granted the GMP certificate by CFDA and its new production lines (6*5000L) by EU standards were completed construction and realized successful trial production in 2015, leading in production scale and quality control in the domestic 勤劳。 As a leading player in the field of domestic pharmaceutical antibody, the company provides targeted drugs for autoimmune diseases, cancer, organ transplantation immunosuppression treatment, with a sustainable capability of drug innovation and 开展。

        请契合环境的攻读学位者将中英文简历、学历证书、身份证副本发送至以下地址:上海市张江高科技园区李冰路399号上海中信广场国健医药品股份股份有限公司 人文资源部 黄先生 接纳(邮递区号):201203) 或 发送E-mail至hr@ (请在信封上或邮递员标题问题上表明应聘获名次)。
请勿来电用电话通知,恕不收到。

点击查看原文:三生国健药业(上海)股份有限公司


知性
下一篇:没有了